For comments, suggestions
Created with Raphaël 2.1.0 11.12.2018 Formal examination (assignment of filing date) 27.12.2018 Preliminary examination 11.02.2019 Establishment of the national regular filing 11.02.2019 Examination of the conditions for granting STPI 30.06.2019 Publication of the decision of grant (Y) 31.12.2019 Completion of the opposition filing period 31.01.2020 Issuance of patent (Z) 11.12.2023 Valid until 27.07.2024 11.12.2024 Patent expiration date

Patent in force


(11)Number of the document1341
(21)Number of the applications 2018 0121
(22)Filing date of the application2018.12.11
(71)Name(s) of applicant(s), code of the countryUNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE "NICOLAE TESTEMITANU" DIN REPUBLICA MOLDOVA, MD; INSTITUTUL DE CARDIOLOGIE DIN REPUBLICA MOLDOVA, MD;
(72)Name(s) of inventor(s), code of the countryBIVOL Elena, MD; GRIB Livi, MD; JUCOVSCHI Constantin, MD;
(73)Name(s) of owner(s), code of the countryUNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE "NICOLAE TESTEMITANU" DIN REPUBLICA MOLDOVA, MD; INSTITUTUL DE CARDIOLOGIE DIN REPUBLICA MOLDOVA, MD;
(54)Title of the inventionMethod for predicting the risk of vascular accidents in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction  
(13)Kind-of-document code
Z, BOPI 01/2020
Y, BOPI 06/2019
(51)International Patent Classification A61B 5/00 (2006.01); A61B 5/0402 (2006.01); A61B 5/20 (2006.01);
(19)CountryMD
(45)Date of publication of patent granting decision:2019.06.30
(47)Date of issuance of patent2020.01.31
(74)Patent attorneyCOŞNEANU Elena, Str. Podul Înalt nr. 12, bloc 2, ap. 12, MD-2023, Chişinău, Republica Moldova
 Substantive examiner(s)GROSU Petru
 Payment for maintenance up to the date2023.12.11
Up
/inventions/Details.aspx?id=s+2018+0121